FBInvestor
Stocks / Contineum Therapeutics Inc
Institutional Ownership

Contineum Therapeutics Inc

CUSIP 21217B100CL ACTNMQ1 2026

No Form 4 insider transactions ingested yet

Insider (Form 4) filings for Contineum Therapeutics Inc are fetched from SEC EDGAR on a rolling basis. Check back shortly.